Albumedix: Medical expertise
Novozymes company Albumedix A/S has appointed Giles Campion new Chief Medical Officer. Campion will be in charge of leading the development efforts of the Danish leader in albumin-based drug delivery.
Prior to joining Albumedix, Campion was Senior Vice President of Research and Development and CMO at Prosensa Holdings and then Group Vice President, Neuromuscular Franchise at Biomarin following the Prosensa acquisition.
Previously, he held positions such as Global Head of Clinical Research and Development at General Electric Healthcare and European Head of Exploratory Clinical Development at Novartis.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium